mechanical allodynia

临床试验

Evaluation of the Efficacy of Somatosensory Rehabilitation of Pain by Vibrotactile Stimulation on Static Mechanical Allodynia

计划入组 17 人 · 首次发布于 2015 年 10 月 8 日

已完成

NCT03553641

The Effect of Central Sensitization on Assessment Capacity of Patients

计划入组 30 人 · 首次发布于 2018 年 6 月 12 日

已完成

NCT00725322

Subcutaneous Botulinum Toxin for Cutaneous Allodynia

计划入组 84 人 · 首次发布于 2008 年 7 月 30 日

药物

查看全部 10 →

Small Molecule

Approved

Atracurium

Rx

Small Molecule

Approved

Cisatracurium(Nimbex)

生产企业：Baxter healthcare corp anesthesia and critical care, Baxter healthcare corp anesthesia critical care，另有 5 家

C₅₃H₇₂N₂O₁₂ · Rx

Small Molecule

Approved

Succinylcholine(Anectine, Quelicin)

生产企业：Sandoz canada inc, Hospira inc，另有 3 家

C₁₄H₃₀N₂O₄ · Rx

机构

查看全部 19 →

Pillar

China Erzhong Group (Deyang) Heavy Industries Co., Ltd.

nVent Electric

United States

资讯

查看全部 375 →

去年

FDA-Approved Apremilast Shows Dual Potential for Alcohol Use Disorder and Pain Management

10个月前

Akeso's AK135 Shows Promise for Chemotherapy-Induced Neuropathy in Preclinical Studies

去年

临床试验

Evaluation of the Efficacy of Somatosensory Rehabilitation of Pain by Vibrotactile Stimulation on Static Mechanical Allodynia

The Effect of Central Sensitization on Assessment Capacity of Patients

Subcutaneous Botulinum Toxin for Cutaneous Allodynia

药物

Atracurium

Cisatracurium(Nimbex)

Succinylcholine(Anectine, Quelicin)

机构

Pillar

China Erzhong Group (Deyang) Heavy Industries Co., Ltd.

nVent Electric

资讯

FDA-Approved Apremilast Shows Dual Potential for Alcohol Use Disorder and Pain Management

Akeso's AK135 Shows Promise for Chemotherapy-Induced Neuropathy in Preclinical Studies

Cerebrolysin Shows Promise in Improving Outcomes After Mechanical Thrombectomy for Acute Stroke